PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy

Condition(s) studied

Investigational drug(s) / intervention(s)

Supportive Care Pathway: All pathways include a medical consultation with comprehensive needs assesment and evidence-based coordinated supportive care referrals at institutional and community-based level.

Study summary

PROACT is a prospective master protocol for a cohort study focused on evaluating the implementation of integrated proactive pathways of supportive care.

This is an observational cohort study in the context of a quality-of-care initiative.

It will be evaluated by its impact on patient's distress measured by the NCCN's Distress thermometer at 12 weeks after entering the pathway.

Eligibility

Primary outcome measure(s)

• Patient distress — over a 12-week period after the integrated supportive care needs assessment.
  Patient distress collected with NCCN Distress Thermometer
• Patient unmet needs — over a 12-week period after the integrated supportive care needs assessment.
  Patient unmet needs collected with problem list from NCCN Distress thermometer

Trial sites (1)

More Gustave Roussy, Cancer Campus, Grand Paris trials in France